Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

News Daily News

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

April 19, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

News Daily News

Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent

September 05, 2012

News Daily News

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

September 05, 2012

News Daily News

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

March 06, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Jason Kahn

March 06, 2012

News Daily News

Ensayo DESTINY: los SLF son Superiores a los SMD en lesiones por debajo de la rodilla

Jason Kahn

March 06, 2012

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

Advertisement

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Ensayo DESTINY: los SLF son Superiores a los SMD en lesiones por debajo de la rodilla

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content